相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Alicia T. Widge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model
Sreelekshmy Mohandas et al.
ISCIENCE (2021)
Biochemical characterization of SARS-CoV-2 nucleocapsid protein
Weihong Zeng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Jose Mateus et al.
SCIENCE (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First isolation of SARS-CoV-2 from clinical samples in India
Prasad Sarkale et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
The who's who of T-cell differentiation: Human memory T-cell subsets
Yolanda D. Mahnke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways
Victoria J. Philbin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
Nikunj M. Shukla et al.
PLOS ONE (2012)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
分享论文
